- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-1-1-3-1-3-1-1-1-1-1-1-1-9-1-mer
- Ligands
- 1 x NAG- NAG- BMA- MAN- MAN- MAN- GLC- GLC- GLC: alpha-D-glucopyranose-(1-2)-alpha-D-glucopyranose-(1-3)-alpha-D-glucopyranose-(1-3)-alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x MAN- MAN: alpha-D-mannopyranose-(1-6)-alpha-D-mannopyranose(Non-covalent)
- 1 x MG: MAGNESIUM ION(Non-covalent)
- 1 x ADP: ADENOSINE-5'-DIPHOSPHATE(Non-covalent)
- 1 x WJP: methyl (3R,6Z,10E,14E)-3,7,11,15,19-pentamethylicosa-6,10,14,18-tetraen-1-yl dihydrogen diphosphate(Non-covalent)
WJP.5: 16 residues within 4Å:- Chain 1: L.150
- Chain Q: S.535, K.539, V.542, F.584, I.591, K.594, S.608, L.609, L.610, F.613, I.614, I.733, T.736, A.737
- Ligands: NAG-NAG-BMA-MAN-MAN-MAN-GLC-GLC-GLC.1
17 PLIP interactions:16 interactions with chain Q, 1 interactions with chain 1- Hydrophobic interactions: Q:K.539, Q:V.542, Q:F.584, Q:I.591, Q:L.610, Q:F.613, Q:I.614, Q:I.733, Q:T.736, Q:A.737, 1:L.150
- Hydrogen bonds: Q:L.609, Q:L.610
- Salt bridges: Q:K.539, Q:K.539, Q:K.594, Q:K.594
- 8 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)
POV.6: 16 residues within 4Å:- Chain R: F.15, V.21, V.22, C.25, Y.26, F.29, L.31, R.34
- Chain U: Y.412, D.415, G.418, F.419
- Chain V: Y.300, Y.304, I.316
- Ligands: POV.23
8 PLIP interactions:5 interactions with chain U, 2 interactions with chain V, 1 interactions with chain R- Hydrophobic interactions: U:F.419, U:F.419, V:I.316, R:F.15
- Hydrogen bonds: U:Y.412
- Salt bridges: U:D.415
- pi-Cation interactions: U:F.419, V:Y.300
POV.7: 20 residues within 4Å:- Chain R: W.16, L.20, G.23, I.24, Y.26, T.27, D.30, G.32, F.35
- Chain U: S.333, A.334, R.335
- Chain X: Y.10, F.14, L.86, F.90
- Chain Y: E.9, Y.10, F.13
- Ligands: POV.8
11 PLIP interactions:3 interactions with chain Y, 4 interactions with chain R, 4 interactions with chain X- Hydrophobic interactions: Y:Y.10, Y:F.13, R:W.16, R:L.20, R:F.35, X:F.14, X:F.90
- Salt bridges: Y:E.9
- Hydrogen bonds: R:D.30, X:Y.10, X:Y.10
POV.8: 15 residues within 4Å:- Chain R: G.32, F.33, D.36, A.38
- Chain U: Y.330, V.332, S.333, W.337, T.360
- Chain W: Y.10, F.14, F.90
- Chain X: Y.10, F.13
- Ligands: POV.7
12 PLIP interactions:2 interactions with chain R, 2 interactions with chain W, 4 interactions with chain U, 4 interactions with chain X- Hydrogen bonds: R:D.36, R:V.37, U:V.332, U:S.333
- Hydrophobic interactions: W:Y.10, W:F.14, U:V.332, X:Y.10, X:Y.10, X:Y.10, X:F.13
- pi-Cation interactions: U:Y.330
POV.9: 19 residues within 4Å:- Chain 3: Y.10, F.13, F.14, F.90
- Chain 4: Y.10, F.13
- Chain U: D.378, S.421, G.423, I.424, G.427, S.431
- Chain V: F.302, P.305, V.306, N.309, L.310, W.313
- Ligands: OLA.20
11 PLIP interactions:5 interactions with chain U, 2 interactions with chain V, 1 interactions with chain 4, 3 interactions with chain 3- Hydrophobic interactions: U:I.424, V:V.306, V:N.309, 4:F.13, 3:F.13, 3:F.13, 3:F.14
- Hydrogen bonds: U:D.378, U:S.421, U:G.423
- Salt bridges: U:D.378
POV.17: 17 residues within 4Å:- Chain 1: Y.10, F.14, M.17, S.20, A.21, F.90
- Chain 2: Y.10, F.13
- Chain V: Y.298, K.299, N.301, Y.304, V.307, F.308, V.311, I.316
- Ligands: POV.19
13 PLIP interactions:5 interactions with chain 1, 6 interactions with chain V, 2 interactions with chain 2- Hydrophobic interactions: 1:F.14, 1:F.14, 1:F.90, V:Y.304, V:V.307, V:F.308, V:V.311, V:I.316, 2:F.13, 2:F.13
- Hydrogen bonds: 1:Y.10, 1:Y.10, V:N.301
POV.18: 14 residues within 4Å:- Chain 3: F.25
- Chain R: G.3, L.4, L.6, L.7, G.10
- Chain U: L.446
- Chain V: L.320, T.321, I.323, V.324, Y.327, N.328
- Ligands: OLA.20
6 PLIP interactions:5 interactions with chain V, 1 interactions with chain 3- Hydrophobic interactions: V:L.320, V:I.323, V:V.324, V:V.324, V:Y.327, 3:F.25
POV.19: 13 residues within 4Å:- Chain 0: Y.10, F.14, M.17, S.20, A.21, L.97
- Chain 1: Y.10, F.13, F.14
- Chain V: Y.298, Y.300, Y.304
- Ligands: POV.17
6 PLIP interactions:2 interactions with chain V, 3 interactions with chain 0, 1 interactions with chain 1- Hydrogen bonds: V:Y.304
- pi-Cation interactions: V:Y.298
- Hydrophobic interactions: 0:F.14, 0:A.21, 0:L.97, 1:F.13
POV.23: 8 residues within 4Å:- Chain 0: Y.10
- Chain R: F.29, D.30
- Chain U: Y.365, Y.412
- Chain Z: Y.10, F.14
- Ligands: POV.6
4 PLIP interactions:1 interactions with chain U, 2 interactions with chain Z, 1 interactions with chain 0- pi-Cation interactions: U:Y.412
- Hydrophobic interactions: Z:F.14, 0:Y.10
- Hydrogen bonds: Z:Y.10
- 7 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
NAG.10: 2 residues within 4Å:- Chain U: N.271, S.273
1 PLIP interactions:1 interactions with chain U- Hydrogen bonds: U:S.273
NAG.11: 3 residues within 4Å:- Chain U: N.294, T.296, D.312
2 PLIP interactions:2 interactions with chain U- Hydrogen bonds: U:N.294, U:N.294
NAG.12: 2 residues within 4Å:- Chain U: F.299, N.301
1 PLIP interactions:1 interactions with chain U- Hydrogen bonds: U:N.301
NAG.13: 5 residues within 4Å:- Chain U: Y.276, F.315, T.317, S.347, N.348
1 PLIP interactions:1 interactions with chain U- Hydrogen bonds: U:F.315
NAG.14: 4 residues within 4Å:- Chain R: D.122
- Chain U: N.342, N.355, D.385
1 PLIP interactions:1 interactions with chain U- Hydrogen bonds: U:N.342
NAG.15: 4 residues within 4Å:- Chain U: D.302, I.364, F.403, N.404
2 PLIP interactions:2 interactions with chain U- Hydrogen bonds: U:F.403, U:N.404
NAG.16: 2 residues within 4Å:- Chain U: N.258, S.260
1 PLIP interactions:1 interactions with chain U- Hydrogen bonds: U:N.258
- 1 x OLA: OLEIC ACID(Non-covalent)
OLA.20: 12 residues within 4Å:- Chain 2: L.97, F.108
- Chain 3: F.25, L.28
- Chain V: I.314, G.317, L.318, T.321, V.324, N.328
- Ligands: POV.9, POV.18
7 PLIP interactions:4 interactions with chain V, 2 interactions with chain 3, 1 interactions with chain 2- Hydrophobic interactions: V:I.314, V:L.318, V:T.321, V:V.324, 3:F.25, 3:L.28, 2:L.97
- 6 x WEV: (5R)-2,4-dideoxy-1-C-{(2S,3R,4S)-3-hydroxy-4-[(2R,3S,4E,6E,9R,10S,11R,12E,14Z)-10-hydroxy-3,15-dimethoxy-7,9,11,13-tetramethyl-16-oxo-1-oxacyclohexadeca-4,6,12,14-tetraen-2-yl]pentan-2-yl}-4-methyl-5-propan-2-yl-alpha-D-threo-pentopyranose(Non-covalent)(Covalent)
WEV.21: 8 residues within 4Å:- Chain W: L.133, F.137, Y.144
- Chain X: M.53, I.56, I.57, V.60, I.64
7 PLIP interactions:3 interactions with chain X, 4 interactions with chain W- Hydrophobic interactions: X:I.56, X:I.57, X:I.64, W:L.133, W:F.137, W:F.137
- Hydrogen bonds: W:Y.144
WEV.22: 6 residues within 4Å:- Chain X: I.136, F.137, Y.144
- Chain Y: M.53, V.60, I.64
5 PLIP interactions:3 interactions with chain Y, 2 interactions with chain X- Hydrophobic interactions: Y:V.60, Y:I.64, X:I.136, X:F.137
- Hydrogen bonds: Y:G.63
WEV.24: 8 residues within 4Å:- Chain Y: L.133, F.137, Y.144
- Chain Z: M.53, I.57, V.60, I.64, I.67
4 PLIP interactions:2 interactions with chain Y, 2 interactions with chain Z- Hydrophobic interactions: Y:L.133, Y:F.137, Z:V.60, Z:I.64
WEV.25: 7 residues within 4Å:- Chain 0: M.53, I.57
- Chain Z: L.133, I.136, F.137, V.140, Y.144
8 PLIP interactions:2 interactions with chain 0, 6 interactions with chain Z- Hydrophobic interactions: 0:I.57, 0:I.57, Z:L.133, Z:I.136, Z:F.137, Z:F.137, Z:V.140
- Hydrogen bonds: Z:Y.144
WEV.26: 5 residues within 4Å:- Chain 2: L.133, I.136, F.137
- Chain 3: M.53, I.64
5 PLIP interactions:4 interactions with chain 2, 1 interactions with chain 3- Hydrophobic interactions: 2:L.133, 2:I.136, 2:F.137, 2:F.137, 3:M.53
WEV.27: 8 residues within 4Å:- Chain 3: L.133, I.136, F.137, V.140, Y.144
- Chain 4: M.53, V.60, I.64
4 PLIP interactions:2 interactions with chain 3, 2 interactions with chain 4- Hydrophobic interactions: 3:I.136, 3:F.137, 4:V.60, 4:I.64
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Wang, R. et al., Molecular basis of V-ATPase inhibition by bafilomycin A1. Nat Commun (2021)
- Release Date
- 2021-03-17
- Peptides
- V-type proton ATPase catalytic subunit A: ABC
V-type proton ATPase subunit B, brain isoform: DEF
V-type proton ATPase subunit C 1: G
V-type proton ATPase subunit D: H
V-type proton ATPase subunit E 1: IJK
V-type proton ATPase subunit F: L
V-type proton ATPase subunit G: MNO
V-type proton ATPase subunit H: P
V-type proton ATPase subunit a: Q
V-type proton ATPase 21 kDa proteolipid subunit: R
V-type proton ATPase subunit d 1: S
V-type proton ATPase subunit e 2: T
V-type proton ATPase subunit S1: U
Renin receptor: V
V-type proton ATPase 16 kDa proteolipid subunit: WXYZ01234
Ribonuclease kappa: 5 - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
FG
GH
HI
IJ
JK
KL
LM
MN
NO
OP
PQ
aR
bS
dT
eU
sV
rW
cX
gY
kZ
l0
m1
n2
o3
p4
q5
f - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-1-1-3-1-3-1-1-1-1-1-1-1-9-1-mer
- Ligands
- 1 x NAG- NAG- BMA- MAN- MAN- MAN- GLC- GLC- GLC: alpha-D-glucopyranose-(1-2)-alpha-D-glucopyranose-(1-3)-alpha-D-glucopyranose-(1-3)-alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x MAN- MAN: alpha-D-mannopyranose-(1-6)-alpha-D-mannopyranose(Non-covalent)
- 1 x MG: MAGNESIUM ION(Non-covalent)
- 1 x ADP: ADENOSINE-5'-DIPHOSPHATE(Non-covalent)
- 1 x WJP: methyl (3R,6Z,10E,14E)-3,7,11,15,19-pentamethylicosa-6,10,14,18-tetraen-1-yl dihydrogen diphosphate(Non-covalent)
- 8 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)
- 7 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
- 1 x OLA: OLEIC ACID(Non-covalent)
- 6 x WEV: (5R)-2,4-dideoxy-1-C-{(2S,3R,4S)-3-hydroxy-4-[(2R,3S,4E,6E,9R,10S,11R,12E,14Z)-10-hydroxy-3,15-dimethoxy-7,9,11,13-tetramethyl-16-oxo-1-oxacyclohexadeca-4,6,12,14-tetraen-2-yl]pentan-2-yl}-4-methyl-5-propan-2-yl-alpha-D-threo-pentopyranose(Non-covalent)(Covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Wang, R. et al., Molecular basis of V-ATPase inhibition by bafilomycin A1. Nat Commun (2021)
- Release Date
- 2021-03-17
- Peptides
- V-type proton ATPase catalytic subunit A: ABC
V-type proton ATPase subunit B, brain isoform: DEF
V-type proton ATPase subunit C 1: G
V-type proton ATPase subunit D: H
V-type proton ATPase subunit E 1: IJK
V-type proton ATPase subunit F: L
V-type proton ATPase subunit G: MNO
V-type proton ATPase subunit H: P
V-type proton ATPase subunit a: Q
V-type proton ATPase 21 kDa proteolipid subunit: R
V-type proton ATPase subunit d 1: S
V-type proton ATPase subunit e 2: T
V-type proton ATPase subunit S1: U
Renin receptor: V
V-type proton ATPase 16 kDa proteolipid subunit: WXYZ01234
Ribonuclease kappa: 5 - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
FG
GH
HI
IJ
JK
KL
LM
MN
NO
OP
PQ
aR
bS
dT
eU
sV
rW
cX
gY
kZ
l0
m1
n2
o3
p4
q5
f - Membrane
-
We predict this structure to be a membrane protein.